Advancing AI to eliminate trial and error in medicine. Read our blog: https://xitter.cf/t.co/u8pjH5CWXk
San Francisco, CA
Joined April 2017
- Tweets1.3K
- Following844
- Followers2.1K
- Likes1.1K
Unlearn.AI retweeted
AI-Powered Patient Replicas: The Future of Drug Development."Excel spreadsheets to AI algorithms" - How @UnlearnAI is creating digital forecasts of patient outcomes, reducing trial sizes, and accelerating drug development timelines by up to 10 months. xitter.cf/i/broadcasts/1kvJpyAol…
Unlearn.AI retweeted
🧬 What are digital twins? AI models that predict how patients would respond to placebos, without giving them one. This means more trial participants get real treatment.
@UnlearnAI's Jon Walsh explains to PYMNTS how this 75-year-old process finally gets modernized in today's Monday Conversation with Karen Webster: hubs.ly/Q03sdF3R0
Unlearn.AI retweeted
We're excited to begin a new partnership with @UnlearnAI to utilize their Digital Twin Generator for #ALS & the Unlearn Platform as we plan our upcoming Phase 1/2 clinical trial in ALS. Read more from CEO @ercgrn below & here: businesswire.com/news/home/2…
Unlearn.AI retweeted
Read our latest Q&A📖 with @UnlearnAI's Steve Herne, who discussed how digital twin AI-generated models may enhance #Alzheimer trials going forward🥼
🔗neurologylive.com/view/utili…
Unlearn.AI retweeted
Radical portfolio company @UnlearnAI is transforming clinical research with the launch of disease-specific Digital Twin Generators (DTGs) for psychiatric disorders. This week’s #RadicalReads shares the details: radical.vc/unlearn-ai-introd…
Unlearn.AI retweeted
Enabling Clinical Trial Innovation Through AI Regulation at FDA medcitynews.com/2024/07/enab…
Unlearn.AI retweeted
“It's a 6-year regulatory journey to get something from ‘here's an idea’ to actually working and getting it through…I think that for a lot of tech companies, that sounds like a long time. But in order to work in this space, this is kind of what it looks like.”—Charles @UnlearnAI
Unlearn.AI retweeted
QurAlis presents! Emma Bowden, PhD, QurAlis' head of development, recently presented an overview of our Phase 1 ANQUR clinical trial - the first-ever study to evaluate a therapy that rescues #STATHMIN-2 (#STMN2) in #ALS - at the 3rd ALS Drug Development Summit. ANQUR is evaluating QRL-201, a first-in-class STMN2 #precisionmedicine for ALS that rescues STMN2 expression in ALS patients and could halt disease progression. QurAlis is exploring the use of the Unlearn.AI Digital Twin Generators in ANQUR. #neurodegenerativediseases
Unlearn.AI retweeted
QurAlis presents! QurAlis' head of development Emma Bowden, PhD, will present an overview of our Phase 1 ANQUR clinical trial evaluating QRL-201 at the 3rd ALS Drug Development Summit. QRL-201 is a first-in-class #STATHMIN-2 (#STMN2) #precisionmedicine for #ALS. ANQUR is the first-ever study to evaluate a therapy that rescues STMN2 expression in ALS patients and could halt disease progression. STMN2 is a well-validated protein important for neural repair and axonal stability, the expression of which is significantly decreased in nearly all ALS patients. QurAlis is exploring the use of the Unlearn.AI Digital Twin Generators in ANQUR with the goal of supporting both ANQUR and future studies for QRL-201. #neurodegenerativediseases bit.ly/3WLZB8l
Unlearn.AI retweeted
Good article on the work that @charleskfisher & his team at @UnlearnAI are doing, using deep learning to make clinical trials smarter — creating digital twins to predict how diseases progress, which speeds up the whole process and helps more people
wsj.com/articles/the-ai-gene…
Unlearn.AI retweeted
💊 @UnlearnAI announces TwinRCT 3.0, elevating Phase 2 clinical trials with digital twins and AI. This game-changing update promises more efficient trials, potentially speeding up new drug development by reducing the need for additional participants.
metaverseinsider.tech/2024/0…
Unlearn.AI retweeted
“What’s gaining adoption that is making a difference in patient care? I think there’s a ton of interesting work being done in AI, from drug discovery to doing chemistry better to how we get treatments to patients quicker.”
@charleskfisher, @UnlearnAI
#RealChemSXSW #SXSW
Unlearn.AI retweeted
While generative AI is revolutionary, experts have acknowledged that deep learning alone can’t achieve true human-like intelligence. So, what does this mean for healthcare?
Our panelists are diving into this and more during our next #RealChemSXSW session!
#client #SXSW
Unlearn.AI retweeted
Better location? Check. Increased square footage? Check. More friendly to dogs? Check.
Another AI company is making big moves in San Francisco commercial real estate. sfstandard.com/2024/02/15/un…
Unlearn.AI retweeted
We're very proud of @DCVC- / @DCVCBio-backed @UnlearnAI's vital work to speed up the development of new drugs for #CrohnsDisease
🌐 This #CrohnsDiseaseAwareness week, we’re shedding light on how AI can help overcome some of the biggest challenges in CD clinical development. Our CD DTG 1.0 enables clinical trials with fewer patients, accelerating clinical development: bit.ly/3uJemwR
#AI
Unlearn.AI retweeted
“We believe AI will become the new language of biology, solving previously insurmountable problems, and transforming medicine from an art form into a predictive science.”
@charleskfisher of @UnlearnAI and @RoetKasper of @QurAlisCo on the promise of #digitaltwins. #CNSSummit2023
Unlearn.AI retweeted
Been heads down cooking this one for a bit. #Parkinsons is a thief of joy and affects millions of families, including some very dear to ours.
So, I’m very excited to be able to share our first step in accelerating trials for new treatments for #Parkinsons. More to come soon.
🚀 With the release of our latest Digital Twin Generator for Parkinson's disease, our DTG suite now covers all major neurological diseases. Learn how this new DTG helps to accelerate or add power to #clinicaltrials in a blog post by #AI scientists Dimitri Theoharatos, Cary Murray, Rishabh Gupta, & Eric Tramel:
bit.ly/3SjCDDz
Unlearn.AI retweeted
Join Charles Fisher and Kasper Roet as they disucss the promise of digital twins with Junaid Bajwa #CNSSummit2023
Unlearn.AI retweeted
We are thrilled to give you a sneak peek into the line up of speakers for #CNSSummit2023. This incredible group of industry leaders are driving meaningful change and having impact at scale. Join us during our 4 day Summit in Boston.
Unlearn.AI retweeted
🗫 Turing-@Roche knowledge share: digital twins in health
🕒 3pm 📅 24 Oct 📍Online 🎫 bit.ly/49bKetV
Explore #DigitalTwins' potential to enable better treatment decisions & outcomes, with speakers from @UnlearnAI & @KingsCollegeLon.
#AI #HealthTech #MachineLearning
